These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 20868615

  • 1. Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee.
    Waugh N, Royle P, Clar C, Henderson R, Cummins E, Hadden D, Lindsay R, Pearson D.
    Health Technol Assess; 2010 Sep; 14(45):1-183. PubMed ID: 20868615
    [Abstract] [Full Text] [Related]

  • 2. The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation.
    Farrar D, Simmonds M, Griffin S, Duarte A, Lawlor DA, Sculpher M, Fairley L, Golder S, Tuffnell D, Bland M, Dunne F, Whitelaw D, Wright J, Sheldon TA.
    Health Technol Assess; 2016 Nov; 20(86):1-348. PubMed ID: 27917777
    [Abstract] [Full Text] [Related]

  • 3. [Gestational diabetes mellitus (Update 2019)].
    Kautzky-Willer A, Harreiter J, Winhofer-Stöckl Y, Bancher-Todesca D, Berger A, Repa A, Lechleitner M, Weitgasser R.
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):91-102. PubMed ID: 30980150
    [Abstract] [Full Text] [Related]

  • 4. [Gestational diabetes mellitus (Update 2023)].
    Kautzky-Willer A, Winhofer Y, Kiss H, Falcone V, Berger A, Lechleitner M, Weitgasser R, Harreiter J.
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):115-128. PubMed ID: 37101032
    [Abstract] [Full Text] [Related]

  • 5. [Impact of HAPO study findings on future diagnostics and therapy of gestational diabetes].
    Schäfer-Graf U.
    Gynakol Geburtshilfliche Rundsch; 2009 Jan; 49(4):254-8. PubMed ID: 20530938
    [Abstract] [Full Text] [Related]

  • 6. The incidence of gestational diabetes mellitus before and after the introduction of HAPO diagnostic criteria.
    Krejčí H, Šimják P, Anderlová K, Benáková H, Pařízek A, Krejčí V, Škrha J.
    Ceska Gynekol; 2019 Jan; 84(6):404-411. PubMed ID: 31948247
    [Abstract] [Full Text] [Related]

  • 7. [Gestational diabetes mellitus].
    Kautzky-Willer A, Harreiter J, Bancher-Todesca D, Berger A, Repa A, Lechleitner M, Weitgasser R.
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S103-12. PubMed ID: 27052232
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gestational diabetes guidelines in a HAPO world.
    Leary J, Pettitt DJ, Jovanovic L.
    Best Pract Res Clin Endocrinol Metab; 2010 Aug; 24(4):673-85. PubMed ID: 20832745
    [Abstract] [Full Text] [Related]

  • 11. Screening for type 2 diabetes: literature review and economic modelling.
    Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.
    Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
    [Abstract] [Full Text] [Related]

  • 12. [Gestational diabetes mellitus].
    Kautzky-Willer A, Bancher-Todesca D, Pollak A, Repa A, Lechleitner M, Weitgasser R.
    Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():58-65. PubMed ID: 23250453
    [Abstract] [Full Text] [Related]

  • 13. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis.
    Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, Dunne F, Lawlor DA.
    BMJ; 2016 Sep 13; 354():i4694. PubMed ID: 27624087
    [Abstract] [Full Text] [Related]

  • 14. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N.
    Health Technol Assess; 2010 Feb 13; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [Abstract] [Full Text] [Related]

  • 15. Towards new diagnostic criteria for diagnosing GDM: the HAPO study.
    Hadar E, Oats J, Hod M.
    J Perinat Med; 2009 Feb 13; 37(5):447-9. PubMed ID: 19725792
    [Abstract] [Full Text] [Related]

  • 16. Gestational diabetes screening: the low-cost algorithm.
    Agarwal MM, Weigl B, Hod M.
    Int J Gynaecol Obstet; 2011 Nov 13; 115 Suppl 1():S30-3. PubMed ID: 22099438
    [Abstract] [Full Text] [Related]

  • 17. Population-Level Outcomes with a 2-Step Approach for Gestational Diabetes Screening and Diagnosis.
    Donovan LE, Edwards AL, Savu A, Butalia S, Ryan EA, Johnson JA, Kaul P.
    Can J Diabetes; 2017 Dec 13; 41(6):596-602. PubMed ID: 28454899
    [Abstract] [Full Text] [Related]

  • 18. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004 Dec 13; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 19. Gestational diabetes: overview of the new consensus screening strategy and diagnostic criteria.
    Benhalima K, Van Crombrugge P, Hanssens M, Devlieger R, Verhaeghe J, Mathieu C.
    Acta Clin Belg; 2012 Dec 13; 67(4):255-61. PubMed ID: 23019800
    [Abstract] [Full Text] [Related]

  • 20. Screening for dysglycaemia during pregnancy: Proposals conciliating International Association of Diabetes and Pregnancy Study Group (IADPSG) and US National Institutes of Health (NIH) panels.
    Cosson E, Valensi P, Carbillon L.
    Diabetes Metab; 2015 Jun 13; 41(3):239-43. PubMed ID: 25282605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.